4//SEC Filing
Breitfeld Philip P. 4
Accession 0001628280-21-005610
CIK 0000771856other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 3:27 PM ET
Size
8.6 KB
Accession
0001628280-21-005610
Insider Transaction Report
Form 4
Breitfeld Philip P.
Director
Transactions
- Exercise/Conversion
Option to purchase Common Stock
2021-03-23−4,167→ 0 totalExercise: $3.65Exp: 2021-04-11→ Common Stock (4,167 underlying) - Exercise/Conversion
Common Stock
2021-03-23$3.65/sh+4,167$15,210→ 4,167 total - Tax Payment
Common Stock
2021-03-23$11.35/sh−1,340$15,209→ 2,827 total
Footnotes (2)
- [F1]Represents a "net exercise" of outstanding stock options. These shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on March 23, 2021.
- [F2]The options vest and are exercisable over a four month period, with vesting to occur on May 1, 2016 and August 1, 2016, respectively.
Documents
Issuer
CHAMPIONS ONCOLOGY, INC.
CIK 0000771856
Entity typeother
Related Parties
1- filerCIK 0001690133
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 3:27 PM ET
- Size
- 8.6 KB